The glucocorticoid receptor in inflammatory processes: transrepression is not enough

Area of Science:

• Pharmacology
• Molecular Biology
• Immunology

Background:

• Glucocorticoids (GCs) are primary anti-inflammatory and immunosuppressive agents.
• Long-term glucocorticoid therapy is associated with significant adverse effects.
• The traditional understanding of GC action relies on transrepression.

Purpose of the Study:

• To challenge the dogma that transrepression is the sole mechanism of GC anti-inflammatory action.
• To investigate the role of transactivation in mediating GC therapeutic effects.
• To explore novel strategies for developing safer glucocorticoid receptor (GR) ligands.

Main Methods:

• Utilized conditional GR mutant mice.
• Employed genomic approaches to analyze gene expression.
• Evaluated the efficacy of GCs in inflammatory disease models.

Main Results:

• Demonstrated that transactivation of specific genes is crucial for suppressing inflammatory responses.
• Provided evidence challenging the exclusive reliance on transrepression for GC-mediated anti-inflammation.
• Identified transactivation as an essential mechanism in various inflammatory disease models.

Conclusions:

• The anti-inflammatory effects of GCs involve both transrepression and transactivation.
• Transactivation of anti-inflammatory genes is critical for therapeutic efficacy.
• This revised understanding facilitates the design of selective GR ligands with improved safety profiles.